Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mismatch Repair01:20

Mismatch Repair

6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Mismatch Repair01:36

Mismatch Repair

43.5K
Overview
43.5K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
Base Excision Repair01:54

Base Excision Repair

25.9K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
25.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeutics.

Molecular therapy. Oncology·2026
Same author

Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasms.

Biophotonics discovery·2026
Same author

Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications.

Current oncology (Toronto, Ont.)·2025
Same author

Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeutics.

bioRxiv : the preprint server for biology·2025
Same author

Therapeutic Effects of Bovine Colostrum on Bone Healing, Rehabilitation, and Postoperative Complications: A Prospective, Randomized, Double-Blinded Comparative Trial.

The Journal of bone and joint surgery. American volume·2025
Same author

SSTR2-Targeted Theranostics in Hepatocellular Carcinoma.

Cancers·2025

相关实验视频

Updated: Jan 10, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.5K

RBM39有助于MGMT维护,以应对Temozolomide诱导的DNA损伤.

Vahid Khalaj1, Jack T Adams1, Solmaz AghaAmiri1

  • 1The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.

Cancers
|November 27, 2025
PubMed
概括

下调RNA结合基因蛋白39 (RBM39) 降低了MGMT蛋白水平,克服了MGMT表达癌症中对temozolomide (TMZ) 化疗的抗性. 结合RBM39和MGMT向,可以提高治疗效率.

关键词:
在MGMTT中,我们可以看到MGMT.这是一个RBM39.化化学疗是一种化化学疗法.神经内分泌新生体的神经内分泌新生体泰莫索洛米德的耐药性

更多相关视频

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

10.9K
Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
05:55

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication

Published on: August 23, 2024

987

相关实验视频

Last Updated: Jan 10, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.5K
Visualization of DNA Repair Proteins Interaction by Immunofluorescence
07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

10.9K
Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
05:55

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication

Published on: August 23, 2024

987

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 癌症治疗方法 癌症治疗方法

背景情况:

  • 对化剂,如temozolomide (TMZ) 的耐药性是治疗MGMT表达瘤的一个主要障碍.
  • MGMT蛋白表达是驱动这种耐药性的关键因素.
  • 已观察到RNA结合基因蛋白39 (RBM39) 与MGMT相关.

研究的目的:

  • 调查RBM39下调对MGMT蛋白水平的影响.
  • 探索针对RBM39和MGMT组合的治疗潜力.

主要方法:

  • 在癌细胞中的RBM39的药理性耗尽和siRNA介导的淘汰.
  • 对MGMT蛋白质水平的评估.
  • 结合疗法研究涉及印苏拉姆 (RBM39抑制剂) 和O6-基氨酸 (MGMT抑制剂).
  • 在神经内分泌瘤细胞中评估亡和克隆生长.

主要成果:

  • 在MGMT表达癌细胞中,RBM39枯竭显著降低了MGMT蛋白水平.
  • 对RBM39和MGMT的双重准协同增强了MGMT的耗尽.
  • 联合印苏拉姆和TMZ治疗增加了细胞亡,并降低了神经内分泌瘤细胞的克隆原生长.

结论:

  • 在MGMT表达癌细胞中,MGMT被确定为RBM39的下游标.
  • 同时准RBM39和MGMT是克服抗化疗耐药性的有希望的策略.
  • 这种方法有可能用于治疗质母细胞瘤和神经内分泌瘤.